Foley & Lardner LLP 代表 BICO Group AB("BICO")达成协议,以 8000 万美元将 MatTek Corp 和 Visikol Inc 出售给 Sartorius Lab Holding GmbH("Sartorius")。此次交易遵循了 BICO 的最新战略,即专注于实验室自动化和选定的工作流程,出售所得资金将用于加强 BICO 的资产负债表并加速其发展议程。交易预计将于 2025 年第二季度完成。
MatTek是体外测试领域领先的3D微组织模型和原代细胞供应商,为动物实验提供更快速、更经济且可重复的替代方案。Visikol专注于先进成像与数字病理学技术。
MatTek的解决方案增强了赛多利斯实验室产品与服务部门在细胞分析仪器、试剂及人工智能支持数据模型方面的产品阵容。整合后的产品组合将成为市场上最全面的解决方案之一,助力科研人员加速新疗法研发进程并减少动物实验。
富乐律师事务所的交易团队由合伙人克里斯托弗·伯恩和加博尔·加赖领衔,成员包括律师格雷厄姆·麦克尤恩和贝莉·绍尔瓦尔德。
人
相关新闻
January 29, 2026
Deals and Wins
Foley Advises Kaia Health on $285M Sale to Sword Health
Foley & Lardner LLP advised Kaia Health, a digital therapeutics company focused on musculoskeletal (MSK) and pulmonary care, on its $285 million sale to Sword Health.
January 26, 2026
Deals and Wins
Foley Advises SkyWater Technology in Agreement to be Acquired by IonQ
Foley & Lardner LLP served as legal advisor to SkyWater Technology (NASDAQ: SKYT), the largest exclusively U.S.-based, pure-play semiconductor foundry, in its definitive agreement to be acquired by IonQ Inc. (NYSE: IONQ), the world’s leading quantum platform company, in a cash-and-stock transaction valuing SkyWater at approximately $1.8 billion.
January 26, 2026
Deals and Wins
Foley Represents Blockstream in Acquisition of Elysium Lab and European Expansion
Foley & Lardner LLP represented Blockstream, the global leader in Bitcoin-powered financial infrastructure, in the acquisition of Lugano-based digital asset company Elysium Lab.